跳至主要内容
临床试验/NCT01641120
NCT01641120已完成不适用

Assessing Tolerability of Avonex Intramuscular Injections With a 25 Gauge Needle Versus 30 Gauge Needle

Trinity Health Of New England1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2012年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Change in Patient Visual Analog Scale Score for Pre-injection Anxiety

研究概览

简要总结

The purpose of this study is to evaluate patients' views when injecting Avonex intramuscularly.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Between 18 - 65 years of age;
  • Confirmed diagnosis of Relapsing Remitting Multiple Sclerosis;
  • Currently being treated with Avonex® for at least 90 days;
  • Using 25 gauge needles for injection of Avonex® for at least 90 days;
  • Willing and able to complete study questionnaires; and
  • Provided informed consent to participate in this study

排除标准

  • Diagnosis of Progressive Multiple Sclerosis;
  • History of recent illness or infection;
  • History of allergic reaction to Avonex®;
  • Any prior usage of a 30 gauge needle for administration of Avonex®;
  • Concurrent treatment with other immunomodulating therapies;
  • Pregnant or planning on becoming pregnant;
  • Nursing mothers; and
  • Unable to complete the requirements of the study

研究组 & 干预措施

30 gauge

Experimental

Subjects used a 30 gauge needle for intramuscular injection of Avonex.

干预措施: Avonex (Drug)

25 gauge

Experimental

Subjects used a 25 gauge needle for intramuscular injection of Avonex.

干预措施: Avonex (Drug)

结局指标

主要结局

Change in Patient Visual Analog Scale Score for Pre-injection Anxiety

时间窗: Weeks 2, 3, 4, 5

The primary endpoint of the study was a change in patient self-reported 100 mm (10 cm) Visual Analogue Scale (VAS) score for pre-injection anxiety. VAS scale (min=0- max=100 mm (10cm)) 0= no anxiety; 100 mm (10 cm)=very severe anxiety. Data from Weeks 2 and 3 were combined and averaged to obtain a single value as both weeks a 30 gauge needle was used for injection. The 30 gauge needle VAS mean refers to the mean for pre-injection anxiety for that needle size. Data from Weeks 4 and 5 were combined and averaged to obtain a single value as both weeks a 25 gauge needle was used for injection. The 25 gauge needle VAS mean refers to the mean for pre-injection anxiety for that needle size.

Visual Analog Scale Score for Post-injection Pain

时间窗: Weeks 2, 3, 4, 5

The primary endpoint of the study was a change in patient self-reported 100 mm (10 cm) Visual Analogue Scale (VAS) score for post-injection pain.VAS scale (min=0 - max=100 mm (10 cm)) 0= no pain; 100 mm (10 cm)=very severe pain. Data from Weeks 2 and 3 were combined and averaged to obtain a single value as both weeks a 30 gauge needle was used for injection. The 30 gauge needle VAS mean refers to the mean for post-injection pain for that needle size. Data from Weeks 4 and 5 were combined and averaged to obtain a single value as both weeks a 25 gauge needle was used for injection. The 25 gauge needle VAS mean refers to the mean for post-injection pain for that needle size.

次要结局

  • Fear of Injection(Weeks 2, 3, 4, 5)
  • Perception of Needle(Weeks 2, 3, 4, 5)

研究者

发起方
Trinity Health Of New England
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验